Michael Aaron Kelly - 10 Aug 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
10 Aug 2024
Transactions value $
$0
Form type
4
Filing time
13 Aug 2024, 16:32:09 UTC
Previous filing
14 Jun 2024
Next filing
27 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +11.3K +55.52% $0.00 31.8K 10 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Restricted Stock Unit Options Exercise $0 -11.3K -100% $0.00* 0 10 Aug 2024 Common Stock 11.3K $0.00 Direct F2
holding NEO Stock Option (Right to Buy) 2.22K 10 Aug 2024 Common Stock 2.22K $37.53 Direct
holding NEO Stock Option (Right to Buy) 3.71K 10 Aug 2024 Common Stock 3.71K $40.90 Direct
holding NEO Stock Option (Right to Buy) 13.9K 10 Aug 2024 Common Stock 13.9K $8.10 Direct
holding NEO Stock Option (Right to Buy) 8.35K 10 Aug 2024 Common Stock 8.35K $14.82 Direct
holding NEO Stock Option (Right to Buy) 8.67K 10 Aug 2024 Common Stock 8.67K $13.71 Direct
holding NEO Restricted Stock Unit 12.3K 10 Aug 2024 Common Stock 12.3K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 Once vested, the shares of common stock are not subject to expiration.